2531 Results (Page 97 of 102)
Healthcare Services Markets Research Reports
Vietnam Hospital Market Analysis
The Vietnam Hospital Market was valued at $27.50 Bn in 2023 and is predicted to grow at a CAGR of 7.83% from 2023 to 2030, to $46.61 Bn by 2030. The key drivers of this industry are rise in chronic diseases, government policies, and medical tourism. The key players in the industry are Vinmec Hospital System, Medlatec Group, Hong Ngoc Hospital System, and City International Hospital among others.
Egypt Hospital Market Analysis
The Egypt Hospital Market was valued at $15.40 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $28.33 Bn by 2030. The key drivers of this industry are the increasing prevalence of chronic disease, technological advancements, and investment in healthcare infrastructure. The key players in the industry are Cleopatra Hospitals Group, Al Safwa Hospital Group, Zohairy Hospital, and Andalusia Hospital among others.
Kenya Hospital Market Analysis
The Kenya Hospital Market was valued at $3.85 Bn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $6.90 Bn by 2030. The key drivers of this industry are increasing demand for quality healthcare, rising prevalence of chronic diseases, and government initiatives. The key players in the industry are Nairobi Hospital, AAR Healthcare, Aga Khan University Hospital, and MP Shah Hospital among others.
Singapore Patient Adherence Programs Market Analysis
The Singapore Patient Adherence Programs Market was valued at $15.5 Mn in 2023 and is predicted to grow at a CAGR of 18.6% from 2023 to 2030, to $51.3 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Singapore Patient Adherence Programs Market are Johnson & Johnson, MSD, Illumina, GSK, Novartis, and Roche, among others.
Indonesia Genomics Market Analysis
The Indonesia Genomics market was valued at $195.9 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $570.6 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Indonesia genomics market are Pandu Biosains, PT Genetika Science, and Eijkman Institute for Molecular Biology, among others.
India Hospital Market Analysis
The India Hospital Market was valued at $100.01 Bn in 2023 and is predicted to grow at a CAGR of 10.6% from 2023 to 2030, to $202.46 Bn by 2030. The key drivers of this industry are the increasing prevalence of chronic disease, technological advancements, and government initiatives. The key players in the industry are Max Healthcare, Sterling Hospitals, Manipal Hospitals, and CARE Hospitals among others.
France Patient Adherence Programs Market Analysis
The France Patient Adherence Programs Market was valued at $356.3 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $1,069.3 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the France Patient Adherence Programs Market are Takeda, Pfizer, Sanofi, Novartis among others
South Africa Hospital Market Analysis
The South Africa Hospital Market was valued at $35.75 Bn in 2023 and is predicted to grow at a CAGR of 8.83% from 2023 to 2030, to $64.64 Bn by 2030. The key drivers of this industry are the rise in geriatric population, technological advancements, and burden of chronic diseases. The key players in the industry are Netcare Group, Mediclinic Southern Africa, Busamed, and Melomed Group among others.
Malaysia Genomics Market Analysis
The Malaysia Genomics market was valued at $52.5 Mn in 2023 and is predicted to grow at a CAGR of 16.70% from 2023 to 2030, to $154.7 Mn by 2030. The key drivers of the market include increasing incidence and prevalence of cancer, the need for advancements in cancer treatments, and the increasing trend of personalized medicines. The prominent players of the Malaysia genomics market are Malaysian Genomics Resource Centre, Codon Genomics, MyTACG Bioscience, Genesis Genome, and Genetics Healthcare Centre, among others.
Germany Patient Adherence Programs Market Analysis
The Germany Patient Adherence Programs Market was valued at $474.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $1,356.4 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players of the Germany Patient Adherence Programs Market are
Philippines Genomics Market Analysis
The Philippines Genomics market was valued at $71.8 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $215.6 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Philippines genomics market are PHIX Genomics, Philippine Genome Centre (PGC), Department of Science and Technology (DOST), Institute of Human Genetics (IHG), among others.
US Financial Assistance Programs Market Analysis
The US Financial Assistance Programs Market was valued at $11,902.5 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $27,315.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Singapore Genomics Market Analysis
The Singapore Genomics market was valued at $39.2 Mn in 2023 and is predicted to grow at a CAGR of 17.10% from 2023 to 2030, to $118.3 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Singapore genomics market are the Genome Institute of Singapore (GIS), NovogeneAIT Genomics, Molecular Genomics, and ACT Genomics, among others.
Saudi Arabia Financial Assistance Programs Market Analysis
The Saudi Arabia Financial Assistance Programs Market was valued at $481.8 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $1,369.8 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda Pharmaceuticals, Teva Pharmaceuticals, GSK, Novartis among others.
South Africa Genomics Market Analysis
The South Africa Genomics market was valued at $212.2 Mn in 2023 and is predicted to grow at a CAGR of 17.73% from 2023 to 2030, to $665.3 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, rising burden of Non-Communicable Diseases (NCDs), and increasing trend of personalized medicines. The prominent players of the South Africa Genomics Market are the South African National Bioinformatics Institute (SANBI), South African Medical Research Council (SAMRC), Illumina, Thermo Fisher Scientific, and Qiagen, among others.
UAE Financial Assistance Programs Market Analysis
The UAE Financial Assistance Programs Market was valued at $141.7 Mn in 2023 and is projected to grow at a CAGR of 15.6% from 2023 to 2023, to $390.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, Teva, Takeda, Merck, GSK, Johnson & Johnson, Novartis among others.
Brazil Financial Assistance Programs Market Analysis
The Brazil Financial Assistance Programs Market was valued at $708.5 Mn in 2023 and is projected to grow at a CAGR of 15.6% from 2023 to 2023, to $1,954.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, AbbVie, Merck, Sanofi, Johnson & Johnson, Novartis among others.
Mexico Financial Assistance Programs Market Analysis
The Mexico Financial Assistance Programs Market was valued at $425.1 Mn in 2023 and is projected to grow at a CAGR of 14.85% from 2023 to 2023, to $1,120.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, AstraZeneca, AbbVie, Merck, GSK, Johnson & Johnson, Novartis among others.
France Financial Assistance Programs Market Analysis
The France Financial Assistance Programs Market was valued at $779.3 Mn in 2023 and is projected to grow at a CAGR of 13.6% from 2023 to 2023, to $1,902.7 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Pierre Fabre, Roche, Merck, GSK, Johnson & Johnson, Novartis among others.
Germany Financial Assistance Programs Market Analysis
The Germany Financial Assistance Programs Market was valued at $1,037.2 Mn in 2023 and is projected to grow at a CAGR of 12.8% from 2023 to 2023, to $2,410.1 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as B. Braun, Boehringer Ingelheim Merck, GSK, Johnson & Johnson, Novartis among others.
Spain Financial Assistance Programs Market Analysis
The Spain Financial Assistance Programs Market was valued at $546.9 Mn in 2023 and is projected to grow at a CAGR of 13.6% from 2023 to 2023, to $1,335.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
UK Financial Assistance Programs Market Analysis
The UK Financial Assistance Programs Market was valued at $736.8 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $1,690.0 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Takeda, AstraZeneca, Bristol Meyer Squibb, Roche, GSK, among others.
China Financial Assistance Programs Market Analysis
The China Financial Assistance Programs Market was valued at $2,278.1 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $6,477.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as CSPC Pharmaceuticals, Cardinal Health, Sinopharm Group Co Ltd, Merck, GSK, Johnson & Johnson, Novartis among others.
Indonesia Financial Assistance Programs Market Analysis
The Indonesia Financial Assistance Programs Market was valued at $170 Mn in 2023 and is projected to grow at a CAGR of 14.6% from 2023 to 2023, to $441.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Mayer, Cipla, Merck, GSK, Johnson & Johnson, Novartis among others.
Japan Financial Assistance Programs Market Analysis
The Japan Financial Assistance Programs Market was valued at $1,761.5 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $4,714.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Daiichi Sankyo Co Ltd, Takeda, Bayer, Baxter, GSK, Johnson & Johnson, Sanofi among others.
